Arrowhead Research signs option agreement for new technology system to kill fat tissue Arrowhead Research Corporation today announced that it has signed an option agreement with The University of Texas MD Anderson Cancer Center to negotiate a permit in a defined field to a class of compounds that’s thought to kill fat cells simply by specifically targeting the blood vessels that supply it. The technology originated in the laboratory of Drs www.nizagara100mg.net nizagara100mg.net . Renata Pasqualini and Wadih Arap at MD Anderson in Houston, Texas. Arrowhead views the technology system as an attractive applicant around which to form a new majority-owned subsidiary to steer the technology through clinical development.
nizagara online australia
The late-breaking data had been presented by Lee Kaplan, M.D., Ph.D., Associate Professor of Medicine at Harvard Medical College and Director of the Massachusetts General Medical center Weight Center, at Obesity 2009, the 27th Annual Scientific Getting together with of The Obesity Society. Related StoriesStanding one-quarter of your day linked to reduced odds of obesityBariatric surgery improves weight, metabolic health and quality of life in adolescents after 3 yearsResearchers find rise in state-level obesity-related healthcare costs’Safety is definitely of paramount importance in dealing with patients who are overweight or have weight problems,’ said Dr.